Finzati - Logo
XERS logo

Xeris Biopharma Holdings, Inc.

XERS • Biotechnology
$8.53
▼ -0.06 (-0.70%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.47B
Growth
13.5%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 30.5%Positive free cash flow · 0.17Healthy liquidity · 2.19Expensive earnings multiple · 2273.17High debt level · 2.76
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:07 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$8.53
Change-0.70%
Shares Out172.82M
Market Cap$1.47B
Enterprise Value$1.61B
52W Range5.25 - 10.08
Beta0.85
P/E-85.88
P/S4.40
P/B-151.45
P/FCF22.71
EV/Sales4.79

Investment DNA

How strong this company looks for long-term investors

52
out of 100
Business Quality
Margins, moat, returns
46/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
29/100
Why this score▼
Positive revenue growth · 30.5%Positive free cash flow · 0.17Healthy liquidity · 2.19Expensive earnings multiple · 2273.17High debt level · 2.76

Analyst view

Analyst sentiment and price target

XERS
Analyst sentiment
Based on 11 analyst votes · 2026-09-05
95/100
Bullish
Bullish
10
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$4.00
Mean
$8.82
Median
$6.60
High
$18.00

Company Overview

IPO: 6/21/2018
Industry: Biotechnology
P/B i: -151.45
Debt / Equity i: 2.76
Operating Margin: 8.53%
Net Margin: 0.19%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 2.76
Current Ratio: 2.19
Quick Ratio: 1.57
Status: Good

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

Hecht Beth
Transaction: 08/03/2026
SELL
Change
-16,666
Price
$8.01
Filing
08/04/2026
Type
SELL
McCulloch Kevin
Transaction: 08/03/2026
SELL
Change
-15,000
Price
$8.02
Filing
08/04/2026
Type
SELL
Pieper Steven
Transaction: 07/07/2026
SELL
Change
-27,600
Price
$8.52
Filing
07/07/2026
Type
SELL